These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27147895)

  • 1. Intravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up.
    Pacella F; Ferraresi AF; Turchetti P; Lenzi T; Giustolisi R; Bottone A; Fameli V; Romano MR; Pacella E
    Ophthalmol Eye Dis; 2016; 8():11-6. PubMed ID: 27147895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An eighteen-month follow-up study on the effects of Intravitreal Dexamethasone Implant in diabetic macular edema refractory to anti-VEGF therapy.
    Pacella F; Romano MR; Turchetti P; Tarquini G; Carnovale A; Mollicone A; Mastromatteo A; Pacella E
    Int J Ophthalmol; 2016; 9(10):1427-1432. PubMed ID: 27803859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
    BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases.
    Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
    Therapie; 2016 Oct; 71(5):457-465. PubMed ID: 27203164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema.
    Pacella E; Vestri AR; Muscella R; Carbotti MR; Castellucci M; Coi L; Turchetti P; Pacella F
    Clin Ophthalmol; 2013; 7():1423-8. PubMed ID: 23901252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of Serous Macular Detachment After Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema.
    Ozdemir MH; Elbay A; Kirik F; Ekinci C; Koytak A
    J Ocul Pharmacol Ther; 2019 Dec; 35(10):558-564. PubMed ID: 31647365
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early efficacy of dexamethasone implant (OZURDEX
    Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
    Rosenblatt A; Udaondo P; Cunha-Vaz J; Sivaprasad S; Bandello F; Lanzetta P; Kodjikian L; Goldstein M; Habot-Wilner Z; Loewenstein A;
    Ophthalmology; 2020 Mar; 127(3):377-393. PubMed ID: 31932090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema.
    Esen E; Sizmaz S; Demircan N
    Int Ophthalmol; 2017 Feb; 37(1):1-6. PubMed ID: 26968412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study.
    Fonollosa A; Zarranz-Ventura J; Valverde A; Becerra E; Bernal-Morales C; Pastor-Idoate S; Zapata MA
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2381-2390. PubMed ID: 31451909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macular edema: Real life safety and efficacy].
    Majstruk L; Qu-Knafo L; Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2020 Mar; 43(3):197-204. PubMed ID: 32000989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series.
    Rishi P; Rishi E; Kuniyal L; Mathur G
    Oman J Ophthalmol; 2012 May; 5(2):79-82. PubMed ID: 22993460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
    Bandello F; Parravano M; Cavallero E; Cascavilla ML; Triolo G; Querques L; Borrelli E; Giorno P; Varano M; Lattanzio R; Querques G
    Ophthalmic Res; 2015; 53(4):207-16. PubMed ID: 25896233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema.
    Mastropasqua R; Toto L; Borrelli E; Di Antonio L; De Nicola C; Mastrocola A; Di Nicola M; Carpineto P
    PLoS One; 2015; 10(12):e0145663. PubMed ID: 26720268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
    Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
    Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal dexamethasone implants for diabetic macular edema.
    Pareja-Ríos A; Ruiz-de la Fuente-Rodríguez P; Bonaque-González S; López-Gálvez M; Lozano-López V; Romero-Aroca P
    Int J Ophthalmol; 2018; 11(1):77-82. PubMed ID: 29375995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema.
    Kim KT; Jang JW; Kang SW; Chae JB; Cho K; Bae K
    Korean J Ophthalmol; 2019 Jun; 33(3):249-258. PubMed ID: 31179656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema.
    Rishi P; Rishi E; Attiku Y; Dhami A; Iyer V
    GMS Ophthalmol Cases; 2020; 10():Doc21. PubMed ID: 32676266
    [No Abstract]   [Full Text] [Related]  

  • 19. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.